Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abeona Therapeutics (ABEO) Goodwill & Intangibles (2016 - 2022)

Abeona Therapeutics has reported Goodwill & Intangibles over the past 11 years, most recently at $2.2 million for Q3 2022.

  • Quarterly results put Goodwill & Intangibles at $2.2 million for Q3 2022, down 93.64% from a year ago — trailing twelve months through Sep 2022 was $2.2 million (down 93.64% YoY), and the annual figure for FY2021 was $1.4 million, down 95.93%.
  • Goodwill & Intangibles for Q3 2022 was $2.2 million at Abeona Therapeutics, roughly flat from $2.2 million in the prior quarter.
  • Over the last five years, Goodwill & Intangibles for ABEO hit a ceiling of $75.5 million in Q4 2018 and a floor of $1.4 million in Q4 2021.
  • Median Goodwill & Intangibles over the past 5 years was $35.1 million (2020), compared with a mean of $36.3 million.
  • Biggest five-year swings in Goodwill & Intangibles: soared 107.48% in 2019 and later plummeted 95.93% in 2021.
  • Abeona Therapeutics' Goodwill & Intangibles stood at $75.5 million in 2018, then decreased by 0.58% to $75.1 million in 2019, then tumbled by 54.76% to $34.0 million in 2020, then crashed by 95.93% to $1.4 million in 2021, then skyrocketed by 55.78% to $2.2 million in 2022.
  • The last three reported values for Goodwill & Intangibles were $2.2 million (Q3 2022), $2.2 million (Q2 2022), and $2.2 million (Q1 2022) per Business Quant data.